The future of International Classification of Diseases coding in steatotic liver disease: an expert panel Delphi consensus statement.
Hagström, Hannes Adams, Leon A Allen, Alina M Byrne, Christopher D Chang, Yoosoo Duseja, Ajay Grønbæk, Henning Ismail, Mona H Jepsen, Peter Kanwal, Fasiha
Hagström, Hannes
Adams, Leon A
Allen, Alina M
Byrne, Christopher D
Chang, Yoosoo
Duseja, Ajay
Grønbæk, Henning
Ismail, Mona H
Jepsen, Peter
Kanwal, Fasiha
Abstract
Background: Following the adoption of new nomenclature for steatotic liver disease, we aimed to build consensus on the use of International Classification of Diseases codes and recommendations for future research and advocacy.
Methods: Through a two-stage Delphi process, a core group (n = 20) reviewed draft statements and recommendations (n = 6), indicating levels of agreement. Following revisions, this process was repeated with a large expert panel (n = 243) from 73 countries.
Results: Consensus ranged from 88.8% to 96.9% (mean = 92.3%).
Conclusions: This global consensus statement provides guidance on harmonizing the International Classification of Diseases coding for steatotic liver disease and future directions to advance the field.
MIDER Authors
Affiliations
Citations
Altmetric:
Date
2024-02-03
Type
Article
Subject
Collections
Citation
Hagström H, Adams LA, Allen AM, Byrne CD, Chang Y, Duseja A, Grønbæk H, Ismail MH, Jepsen P, Kanwal F, Kramer J, Loomba R, Mark HE, Newsome PN, Rinella ME, Rowe IA, Ryu S, Sanyal A, Schattenberg JM, Serper M, Sheron N, Simon TG, Spearman CW, Tapper EB, Villota-Rivas M, Wild SH, Wong VW, Yilmaz Y, Zelber-Sagi S, Åberg F, Lazarus JV. The future of International Classification of Diseases coding in steatotic liver disease: An expert panel Delphi consensus statement. Hepatol Commun. 2024 Feb 3;8(2):e0386. doi: 10.1097/HC9.0000000000000386.